On the recordApril 10, 2024
Would you say that in the case of Copaxone where Teva is asking for more patents... that could be frivolous?
Source
congress.govWould you say that in the case of Copaxone where Teva is asking for more patents... that could be frivolous?
Khanna questions the validity of multiple patents extending drug prices.
Share
More from Ro Khanna
This is one of the boldest industrialization proposals since FDR’s industrialization efforts, and it’s in the tradition of Hamilton’s efforts.
And then they call the IDF and the IDF is on their side, not on the side of the Americans.